Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Essential Hypertension”

82 trials

Showing 20 of 82 results

Post-approval studies (Phase 4)Study completedNCT02495324
What this trial is testing

Fimasartan Achieving SBP Target (FAST) Study

Who this might be right for
Essential,Hypertension
Boryung Pharmaceutical Co., Ltd 369
Large-scale testing (Phase 3)Study completedNCT00392262
What this trial is testing

Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

Who this might be right for
Hypertension
Novartis 224
Not applicableStudy completedNCT07375407
What this trial is testing

Aerobic Exercise vs Physiological Ischemic Training in Stage 2 Hypertension

Who this might be right for
Primary Hypertension, Grade 2
Universitas Padjadjaran 60
Testing effectiveness (Phase 2)Study completedNCT02222480
What this trial is testing

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 103
Post-approval studies (Phase 4)Study completedNCT00302705
What this trial is testing

Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose

Who this might be right for
Hypertension
University of Vigo 150
Large-scale testing (Phase 3)Study completedNCT01631227
What this trial is testing

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Who this might be right for
Essential Hypertension
Abbott 665
Testing effectiveness (Phase 2)Study completedNCT00710372
What this trial is testing

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Who this might be right for
Mild Essential HypertensionModerate Essential Hypertension
Cytos Biotechnology AG 83
Testing effectiveness (Phase 2)UnknownNCT05033535
What this trial is testing

S086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shenzhen People's Hospital 10
Large-scale testing (Phase 3)Study completedNCT02206659
What this trial is testing

Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 20
Testing effectiveness (Phase 2)Study completedNCT01303783
What this trial is testing

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension

Who this might be right for
Hypertension, Essential
Bayer 1,381
Large-scale testing (Phase 3)Study completedNCT00857285
What this trial is testing

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 130
Large-scale testing (Phase 3)Study completedNCT00257491
What this trial is testing

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 29
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT06716970
What this trial is testing

QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension

Who this might be right for
Essential Hypertension
Wuhan Createrna Science and Technology Co., Ltd 810
Post-approval studies (Phase 4)Study completedNCT00328965
What this trial is testing

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Who this might be right for
Diabetes Mellitus, Type 2Essential Hypertension
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT01033071
What this trial is testing

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Who this might be right for
Essential Hypertension
Takeda 1,071
Large-scale testing (Phase 3)Study completedNCT00220220
What this trial is testing

Amlodipine as add-on to Olmesartan in Hypertension

Who this might be right for
Essential Hypertension
Sankyo Pharma Gmbh 429
Large-scale testing (Phase 3)Not Yet RecruitingNCT06771245
What this trial is testing

A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

Who this might be right for
Mild-to-moderate Essential Hypertension
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 606
Large-scale testing (Phase 3)WithdrawnNCT02969265
What this trial is testing

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

Who this might be right for
Hypertension
Takeda
Post-approval studies (Phase 4)Study completedNCT00765947
What this trial is testing

Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

Who this might be right for
Essential Hypertension ( Mild to Moderate)
Novartis 256
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation